INTRODUCTION
Both the American Academy of Pediatrics (Task Force on Newborn and Infant Hearing) and the Joint Committee on Infant Hearing (JCIH) have endorsed universal newborn hearing screening.
1,2 The Task Force and JCIH indicated that universal screening is warranted based upon evidence that (1) significant congenital hearing loss is relatively common (compared with other abnormalities, which are currently screened for in the newborn period); (2) significant hearing loss can be detected by screening with physiologic measures; (3) hearing loss cannot be detected by other means; (4) early intervention at less than 6 months of age is effective in improving outcome; (5) the physiologic screening methods are portable, accurate, and easy to use; and (6) the cost of performing hearing screening is acceptable. As a result of the position statement of the American Academy of Pediatrics and other organizations, universal newborn hearing screening programs have evolved rapidly; currently, more than 30 states have enacted legislation mandating universal newborn hearing screening. 3 However, there are relatively few published studies that have evaluated the costs associated with establishing and operating hearing screening programs. We undertook the present study to provide a comprehensive comparison of the costs and outcomes associated with the start-up phase of hearing screening programs, using transient evoked otoacoustic emission (TEOAE) or automated auditory brainstem response (AABR) technologies.
METHODS
Two newly established, hospital-based, universal newborn hearing screening programs were prospectively studied. One program employed TEOAE screening (Rainbow Babies' and Children's
OBJECTIVE:
To evaluate the costs and performance characteristics associated with the start -up phase of Universal Newborn Hearing Screening Programs, one utilizing automated auditory brainstem response ( AABR ) and the other using transient evoked otoacoustic emissions ( TEOAE ).
STUDY DESIGN:
Economic and performance data were collected at the initiation of both screening programs. Data were collected until 1500 newborn infants were screened or until a referral rate for further audiologic evaluation at hospital discharge of less than or equal to 5% was achieved. Data collected included screening pass / fail rates, referral rates and personnel, equipment, and supply utilization. Actual costs of personnel, equipment, and supplies were used. Statistical comparisons of proportions using z -statistic with the onetailed test and an of 0.01 were made.
RESULTS:
Screening in the AABR program was performed by neonatal nurses, whereas screening in the TEOAE program was performed by master's level audiologists. The average age at initial screen was 29 hours for TEOAE, and 9.5 hours for AABR. Eighty -four percent of infants was screened within 24 hours in the AABR program, in contrast to 35% in the TEOAE program. Throughout the duration of the study, the referral rate at hospital discharge remained approximately 15% for the TEOAE program. The AABR referral rate began at 8% and was less than 4% at the completion of the study. Predischarge total costs for initiating and establishing the programs were US$49,316 for TEOAE and US$47,553 for AABR. Cost per infant screened was US$32.23 and US$33.68, respectively. When post -discharge screening and diagnostic evaluation costs were included, the total cost per infant screened was US$58.07 for TEOAE and US$45.85 for AABR.
CONCLUSION: AABR appears to be the preferred method for universal newborn hearing screening. AABR was associated with the lowest costs, achieved the lowest referral rates at hospital discharge, and had the quickest learning curve to achieve those rates. Original Article
Hospital, Cleveland, OH), and one used AABR screening (Wishard Memorial Hospital, Indianapolis, IN). All newborn infants were screened for hearing loss prior to discharge from the newborn nursery. Those who failed the initial screen, either unilaterally or bilaterally, were rescreened one or more times using the same technology. Those who had not passed by the time of discharge were referred for follow-up screening. A site was considered to have completed the study when either 1500 babies were screened, or a 5% or lower referral rate was achieved for two consecutive months. A 5% referral rate was considered to be indicative of a ''trained'' site that was no longer in its start-up phase. Full screening protocols were established at both hospital sites, and used standard pass/fail endpoints. The study at the TEOAE site was initiated in February 1999 and completed in 5 months with screening of 1530 infants. The study at the AABR site was initiated in January 1999 and completed in 8 months with screening of 1412 infants. TEOAE screening employed ILO88 instruments (Otodynamics, Hatfield, England). Pass criteria for TEOAE were (1) at least 50 quiet emissions collected; (2) response present in the frequency bands of 2.4, 3.2, and 4.0 kHz with a signal-to-noise ratio of at least 3 dB at each marked point within the band; (3) stimulus between 76 and 86 dB SPL (not to exceed 87 dB peak SPL); and (4) reproducibility of at least 75% for frequency bands of 2.4, 3.2, and 4.0 kHz. All AABR screenings were performed on an ALGO 2e machine (Natus Medical, San Carlos, CA). AABR pass was achieved when the following criteria were met: for 35 dB nHL clicks, sufficient data collected to establish with 99.96% statistical confidence that an ABR signal was present and consistent with a template at a minimum of 1000 sweeps. If it was not established with 99.96% statistical confidence that the ABR signal was present for 35 dB nHL clicks at 15,000 sweeps, the infant was considered an AABR fail and referred. 4, 5 Data were collected prospectively on the initial screen and rescreen. Data included gender, postnatal age at the time of screen, the infant's state (e.g., sleeping, quiet, fussy), screening start and end times, results and recommendations (i.e., pass or outpatient rescreen). Screeners were responsible for completing the data forms, and were monitored by the audiologist at each site. Independent site audits were performed regularly to ensure accuracy, completeness, and consistency of screening and data collection. Figure 1 . The percentage of infants who are referred at discharge is presented for each of 300 infants screened. The percentage referred decreases for AABR as more infants are screened ( 8.3% to 4%), whereas the percent referred TEOAE remains 15% throughout the study period. Resource utilization data were also collected and included personnel type, screening time, time invested in scheduling and follow-up for rescreens, time devoted to administrative management of the program, training costs of personnel, and equipment (i.e., screening equipment and supplies, computer and printer for each program, educational materials and other data forms). Values for resource costs were assigned in 1999 dollars. Salaries and wages for personnel were obtained from the US Bureau of Labor Statistics 6 and published infant hearing screening literature 7 -9 (Vohr BR, 2001, personal communication). The study was approved by the institutional review board of each institution.
ANALYSIS METHODS
Statistical comparisons of proportions were made using the zstatistic with the one-tailed test and an of 0.01. Characteristics of each program were compared, including screening times, referral rates after initial and follow-up screen, changes in referral rates over time, and costs of each program.
RESULTS
The characteristics of the two programs are presented in Table 1 . In the TEOAE program, two screeners (both master's level audiologists completing their clinical fellowship) performed 82% of the screens, with five other screeners performing the remainder. The screening at the AABR site was conducted by 26 neonatal nurses, with the majority of screens performed by four nurses who completed 61% of the screens. The majority of infants at the AABR site were discharged within 24 hours after birth (per hospital policy), whereas the majority at the TEOAE site were discharged at or near 48 hours (per hospital policy). The average age at initial screen was 29 hours for the TEOAE program, and 9.5 hours for the AABR program. Approximately 50% of infants in the AABR program was screened prior to 6 hours postnatal age, with 84% screened within 24 hours. Only 35% was screened within 24 hours in the TEOAE program.
During the study, 99% of infants was successfully screened in the TEOAE program, whereas 96% was screened in the AABR program. Eighty-one percent of infants passed the initial TEOAE screen, and 15.7% of infants was referred for further evaluation at discharge. In the AABR program, 77% passed the initial screen, and 6.5% ultimately was referred for further evaluation at discharge. The Figure 1 ). In contrast, the AABR site experienced a learning curve with a decrease in the referral rate from approximately 8% at the beginning of the program to 4% at the end of the study period ( Figure 1 ). The time required for screening was 5±3 (SD) minutes for TEOAE, and 13±12 (SD) minutes for AABR. The actual costs for each program based upon 1999 data are summarized in Tables 2-5 . The costs per unit of personnel, equipment, and supplies are provided in Table 2 . The actual total personnel costs required for screening approximately 1500 infants in each program are depicted in Table 3 . Personnel costs were significantly higher for the TEOAE program than the AABR (US$36,024 vs US$14,116), as dedicated staff were hired for the TEOAE program. In addition, audiologist time was greater, reflecting additional time required for results interpretation, training and follow-up for the TEOAE. Finally, administrative time was higher for the TEOAE program, as a result of the higher referral rate and increased need for scheduling and follow-up of infants. The total costs for starting each program are represented in Table 4 and are remarkably similar (US$49,316 vs US$47,553). The cost per infant screened was US$32.23 for TEOAE and US$33.68 for AABR. These cost calculations do not include post-discharge screening costs. As presented in Table 5 , because of the higher referral rate at discharge for the TEOAE program, post-discharge screening and diagnostic evaluation costs would be more than twice as high for the TEOAE compared to the AABR program. When these are included, the cost per infant screened increases to US$58.07 for TEOAE and US$45.85 for AABR.
DISCUSSION
Over 50% of infants born in the United States had hearing screening in the newborn period in the year 2000. Most hearing screening programs use either (1) otoacoustic emission for the initial and repeat screen, (2) AABR for the initial and rescreen, or (3) an initial OAE followed by a rescreen AABR. In an evaluation of 120 ongoing programs, the reported pass rate at discharge was 96% for ABRbased programs, and 92% for OAE-based programs. 10 In other words, OAE-based programs had twice the refer rate at discharge as ABR-based programs. These data are consistent with the findings of the present study. Only the AABR program was able to achieve the goal of a refer rate of 5% or less at hospital discharge. A clear learning curve was observed for the AABR program, with an initial refer rate of 8.3% for the first 300 infants screened to 4.0% for the last 300 screened. No change was observed in the refer rate for the TEOAE program, which remained at approximately 15% throughout the study period.
The two study sites differed in several important characteristics: screener type (''nondedicated'' for AABR versus ''dedicated'' for TEOAE), number of screeners (26 AABR vs 7 TEOAE), age at initial screen (9.5 hours AABR vs 29.1 hours TEOAE), and mean nursery discharge age (24 hours AABR vs 48 hours TEOAE). Based upon results of a previous study conducted in established screening programs, each of these differences would increase the refer rate in the AABR program, and decrease the referral rate in the TEOAE program (Vohr BR, 2001, personal communication) . Nonetheless, the AABR site had the lowest referral rate, and therefore the lowest follow-up requirement.
Total costs of each program for screening 1500 infants were remarkably similar. The cost per infant screened was approximately US$30 for each program, also similar to that reported for the Rhode Island program (approximately US$26 per infant screen). 11 However, because of the higher referral rate at discharge, the costs of tracking, follow-up, and rescreening are greater for the TEOAE program. When including these costs for each program, the cost per infant screened increases to US$58 for TEOAE and US$46 for AABR. These cost estimates for starting/establishing a program are higher, as would be expected, than those required to maintain a program.
Although costs associated with newborn hearing screening programs are multifactorial, the major determinants are personnel and the referral rate at hospital discharge. If neonatal nurses performed the screening in the TEOAE program in the same manner as for the AABR program, the personnel costs would be reduced significantly for the TEOAE program. Assuming that the postdischarge costs remained unchanged and nurses performed the screening in both programs, the total costs for each would be US$67,147 for TEOAE and US$64,739 for AABR. This results in a cost per infant screened of US$44 for TEOAE and US$46 for AABR. Therefore, assuming minimal personnel costs for both programs, the total start-up costs are essentially the same for each. However, the TEOAE program is left with a significantly higher referral rate.
Both the American Academy of Pediatrics and JCIH have emphasized the importance of achieving a referral rate of <4% at discharge from the hospital.
1,2 As tracking and follow-up of newborn infants in most rural or large urban centers are extremely difficult and expensive, Grein et al. 15 reported that the cost of identifying a child with hearing loss increased by US$1800 for each percent increase in referral rate at hospital discharge, regardless of the screening methodologies. Furthermore, the higher the referral rate at discharge, the greater the likelihood that infants who have significant hearing loss will be missed because of inability to locate and rescreen. The results of this study are consistent with previously published data, 12 -14 indicating that AABR appears to be the preferred method for universal newborn hearing screening. AABR has the lowest cost to become trained, achieves the lowest referral rates at hospital discharge, and has the quickest learning curve to achieve those rates.
